DI
SLS icon

DAGCO Inc’s SELLAS Life Sciences SLS Stock Holding History

DAGCO Inc’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Buy
1,232,433
+203,653
+20% +$1.41M 3.36% 10
2026
Q1 		$4.35M Buy
1,028,780
+451,240
+78% +$2.02M 0.94% 23
2025
Q4 		$2.18M Buy
+577,540
New +$1.12M 0.5% 34

Other funds holding SLS

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
FWA
Fulcrum Wealth Advisors Bellevue, Washington $131M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
VH
Visionary Horizons Knoxville, Tennessee $239M AUM 22.35% 1-Year Est. Return
FD
Financial Designs Claremont, California $187M AUM 14.59% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
MCA
Martin Capital Advisors San Antonio, Texas $191M AUM 42.42% 1-Year Est. Return

DAGCO Inc's SLS Position: Q2 2026 in Review

DAGCO Inc increased its SELLAS Life Sciences (SLS) stake by 20% in Q2 2026, buying an estimated $1.41M and bringing the position to 1,232,433 shares worth $18.2M. The position accounts for 3.36% of the portfolio, ranked #10.

DAGCO Inc first reported a position in SLS in Q4 2025 and has held it in 3 quarters since. 28 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • DAGCO Inc held 1,232,433 shares of SELLAS Life Sciences worth $18.2M as of Q2 2026.
  • DAGCO Inc bought 203,653 SELLAS Life Sciences shares in Q2 2026, an estimated $1.41M.
  • SELLAS Life Sciences made up 3.36% of DAGCO Inc's portfolio in Q2 2026, its #10 holding.
  • DAGCO Inc first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 28 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on DAGCO Inc's 13F filing for Q2 2026, filed 10 Jul 2026.